Functional nitric oxide synthase mislocalization in cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YJMCC.2003.09.020PMID 14871549
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nitric oxide and excitation-contraction coupling.

  2003cited by this paper
• Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy.

  2002cited by this paper
• Dystrophin‐deficient cardiomyocytes are abnormally vulnerable to mechanical stress‐induced contractile failure and injury

  2001cited by this paper
• Nitric oxide synthases: structure, function and inhibition.

  2001cited by this paper
• Hsp90 Ensures the Transition from the Early Ca2+-dependent to the Late Phosphorylation-dependent Activation of the Endothelial Nitric-oxide Synthase in Vascular Endothelial Growth Factor-exposed Endothelial Cells*

  2001cited by this paper
• Cardiomyopathy in animal models of muscular dystrophy

  2001cited by this paper
• Myocardial Contractile Function and Heart Rate in Mice With Myocyte-Specific Overexpression of Endothelial Nitric Oxide Synthase

  2001cited by this paper
• A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

  2001cited by this paper
• Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein

  2000cited by this paper
• Sarcoglycans in muscular dystrophy

  2000cited by this paper
• Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex.

  2000influential reference
• Filamin 2 (Fln2)

  2000cited by this paper
• Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy.

  1999cited by this paper
• Role for α-Dystrobrevin in the Pathogenesis of Dystrophin-Dependent Muscular Dystrophies

  1999cited by this paper
• Limb-girdle muscular dystrophies: an overview.

  1999cited by this paper
• Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies

  1999cited by this paper
• Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore.

  1998cited by this paper
• Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice

  1998cited by this paper
• γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin

  1998cited by this paper
• Identification of the Syrian hamster cardiomyopathy gene.

  1997cited by this paper
• Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin

  1997cited by this paper
• Animal Models for Muscular Dystrophy Show Different Patterns of Sarcolemmal Disruption

  1997cited by this paper
• Beyond dystrophin: current progress in the muscular dystrophies.

  1996cited by this paper
• Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells.

  1996cited by this paper
• Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy

  1996cited by this paper
• Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy

  1996cited by this paper
• Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy.

  1996cited by this paper
• Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy.

  1995influential reference
• Nitric Oxide-dependent Parasympathetic Signaling Is Due to Activation of Constitutive Endothelial (Type III) Nitric Oxide Synthase in Cardiac Myocytes (*)

  1995cited by this paper
• Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle.

  1995influential reference
• Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside.

  1994cited by this paper
• Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

  1993cited by this paper
• Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

  1993cited by this paper
• Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice

  1991cited by this paper
• Microvascular Spasm in the Cardiomyopathic Syrian Hamster: A Preventable Cause of Focal Myocardial Necrosis

  1982cited by this paper
• Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster.

  1975cited by this paper

• Cellular pathology of the human heart in Duchenne muscular dystrophy (DMD): lessons learned from in vitro modeling

  2021cites this paper
• LGMD. Identification, description and classification

  2020cites this paper
• Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts.

  2019cites this paper
• Preclinical Models of Dystrophic Cardiomyopathy and Therapies for the Dystrophic Heart

  2019cites this paper
• Changes in vascular reactivity of the coronary artery and thoracic aorta in the delta sarcoglycan null mutant mice

  2017cites this paper
• Using Zebrafish for High-Throughput Screening of Novel Cardiovascular Drugs

  2017cites this paper
• Pathogenesis, clinical features and diagnosis of sarcoglycanopathies

  2016cites this paper
• muscular dystrophy The role of free radicals in the pathophysiology of

  2015cites this paper
• Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy

  2014cites this paper
• Glutathionylation Mediates Angiotensin II–Induced eNOS Uncoupling, Amplifying NADPH Oxidase‐Dependent Endothelial Dysfunction

  2014cites this paper
• Nitric oxide-loaded echogenic liposomes for treatment of vasospasm following subarachnoid hemorrhage

  2013cites this paper
• Recent advances in in vivo screening for antiarrhythmic drugs

  2013cites this paper
• Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil.

  2011cites this paper
• Neuronal Nitric Oxide Synthase-Rescue of Dystrophin/Utrophin Double Knockout Mice does not Require nNOS Localization to the Cell Membrane

  2011cites this paper
• Cardiac arrhythmia: in vivo screening in the zebrafish to overcome complexity in drug discovery

  2010cites this paper
• Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

  2010cites this paper
• Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

  2009cites this paper
• Dystroglycan Matrix Receptor Function in Cardiac Myocytes Is Important for Limiting Activity-Induced Myocardial Damage

  2009cites this paper
• Sarcolemmal Neuronal Nitric Oxide Synthase Defect in Limb-Girdle Muscular Dystrophy: An Adverse Modulating Factor in the Disease Course?

  2009cites this paper
• Isoproterenol induces primary loss of dystrophin in rat hearts: correlation with myocardial injury

  2008cites this paper
• Nuclear sequestration of delta-sarcoglycan disrupts the nuclear localization of lamin A/C and emerin in cardiomyocytes.

  2007cites this paper
• The role of free radicals in the pathophysiology of muscular dystrophy.

  2007cites this paper
• Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.

  2007cites this paper
• Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart Failure

  2007cites this paper
• Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy.

  2007cites this paper
• lamin A/C and emerin in cardiomyocytes

  2006cites this paper
• Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle.

  2006cites this paper
• Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses.

  2006influential citation
• Increased Nitration of Sarcoplasmic Reticulum Ca 2 (cid:1) -ATPase in Human Heart Failure Heart Failure

  2005cites this paper
• Modifying function and fibrosis of cardiac and skeletal muscle from mdx mice

  2005cites this paper
• Increased Nitration of Sarcoplasmic Reticulum Ca2+-ATPase in Human Heart Failure

  2005cites this paper
• Cardiac involvement in muscular dystrophies: Molecular mechanisms

  2005cites this paper
• The interaction of coronary tone and cardiac fibrosis

  2005cites this paper
• Sarcolemma The Dystrophin Glycoprotein Complex : Signaling Strength and Integrity for the Print

  2004cites this paper
• The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma.

  2004cites this paper
• Regenerating more than muscle in muscular dystrophy.

  2004cites this paper
• Cardiomyopathy in muscular dystrophy workshop. 28-30 September 2003, Tucson, Arizona.

  2004cites this paper
• Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy.

  2004cites this paper